Pilot Study of Natriuretic vs. Standard Doses of Mineralocorticoid Receptor Antagonists in Heart Failure and Loop Diuretic Resistance
Spironolactone in heart failure patients
Sponsor: Herbert Irving Institute
Enrolling: Male and Female Patients
Study Length: 2 Days
Clinic Visits: 3
IRB Number: AAAO9102
Contact: Rosa Aponte Medina MD: 201-682-4817 / rda2120@cumc.columbia.edu
Additional Study Information: The purpose of this outpatient study is to examine if oral Spironolactone (100mg/day) in addition to loop diuretics (water pills) can improve signs and symptoms of fluid retention in patients with heart failure and prevent hospitalization.
This study is closed
Investigator
Arthur Reshad Garan, MD
Do You Qualify?
Do you have heart failure? Yes No
Are you taking water pills? Yes No
Have you experienced any weight gain recently? Yes No
Are you having shortness of breath or experiencing leg swelling? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Rosa Aponte Medina MD
rda2120@cumc.columbia.edu
201-682-4817
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE